Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications

Nicolaj C Hansson1, Erik L Grove2, Henning R Andersen1

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Insights

Transcatheter heart valve (THV) thrombosis occurred in 7% of patients post-transcatheter aortic valve replacement (TAVR). Larger THV size increased risk, while warfarin treatment showed a protective effect against THV thrombosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Limited data exists on transcatheter heart valve (THV) thrombosis post-transcatheter aortic valve replacement (TAVR).
  • Understanding incidence, clinical impact, and risk factors for THV thrombosis is crucial.

Purpose of the Study:

  • To assess the incidence of THV thrombosis after TAVR.
  • To identify predictors and clinical implications of THV thrombosis.
  • To evaluate the effectiveness of warfarin in managing THV thrombosis.

Main Methods:

  • Contrast-enhanced multidetector computed tomography (MDCT) was used to evaluate 405 patients post-TAVR.
  • MDCT scans were analyzed for hypoattenuated leaflet thickening, indicating THV thrombosis.
  • Follow-up imaging assessed the impact of warfarin treatment.

Main Results:

  • THV thrombosis was detected in 7% of patients (28/405).
  • Larger THV size (29-mm) and absence of warfarin treatment were independent predictors of THV thrombosis.
  • Warfarin treatment was associated with a significantly lower risk of THV thrombosis (1.8% vs. 10.7%).

Conclusions:

  • THV thrombosis occurs in 7% of patients post-TAVR, often subclinically.
  • Larger THV size is a risk factor, while warfarin may be protective.
  • THV thrombosis has significant clinical implications, but warfarin treatment can effectively reverse it.
Abstract

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
634
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
481
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
618